The P2RY2 enhancer RNA (P2RY2e) has been validated as an estrogen-responsive eRNA and has been involved in the development of breast cancer and the progression of bladder cancer (Ding et al. 2018). The gene discussed is P2RY2; the disease is urinary bladder carcinoma.